Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

A15722 Ellagic acid hydrate, 97%, may cont. up to 12% water

CAS Number
476-66-4
Synonyms
4,4',5,5',6,6'-Hexahydroxydiphenic acid 2,6,2',6'-dilactone hydrate

Stock No. Size Price ($) Quantity Availability
A15722-06 5g 43.10
A15722-14 25g 153.00
A15722-22 100g 460.00
Add to Cart Bulk/Specialty Print Quote View Item

Ellagic acid hydrate, 97%, may cont. up to 12% water

MDL
MFCD00149494
EINECS
207-508-3

Chemical Properties

Formula
C14H6O8•xH2O
Formula Weight
302.20(anhy)
Melting point
450° dec.
Storage & Sensitivity
Air Sensitive. Light Sensitive. Ambient temperatures.
Solubility
Slightly soluble in water. Soluble in 1M sodium hydroxide (10 mg/ml), EtOH, and pyridine.

Applications

Ellagic acid used as selective, ATP-competitive inhibitor of casein kinase 2. Exhibits antitumor activity and inhibits glutathione S-transferase. It is also used as a Topo I and II, FGR, GSK, and PKA inhibitor.Commonly occurring plant polyphenol, inhibitor of glutathione S-transferase. Used for the assay of factor XIIa in plasma.Contact activation in blood coagulation.

Notes

Air sensitive and light sensitive. Store under dry inert gas. Store in cool dry place in tightly closed container. Store in dark and away form air.

Literature References

Patrice Njomnang Soh: Benoît Witkowski; David Olagnier; Marie-Laure Nicolau; Maria-Concepcion Garcia-Alvarez; Antoine Berry; and Françoise Benoit-Vical. In Vitro and In Vivo Properties of Ellagic Acid in Malaria Treatment. Antimicrob. Agents Chemother. 2009, 31100-1106.

Sungwoo Kim; Satoru K. Nishimoto; Joel D. Bumgardnerd; Warren O. Haggardd; M. Waleed Gabere; Yunzhi Yang. A chitosan/β-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Biomaterials. 2010, 31 (14), 4157-4166.

GHS Hazard and Precautionary Statements

Hazard Statements: H315-H319-H335

Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.

Precautionary Statements: P261-P264b-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P501c

Avoid breathing dust/fume/gas/mist/vapours/spray. Wash face, hands and any exposed skin thoroughly after handling Use only outdoors or in a well-ventilated area. Wear protective gloves/protective clothing/eye protection/face protection. IF ON SKIN: Wash with plenty of soap and water. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Call a POISON CENTER or doctor/physician if you feel unwell. If skin irritation occurs: Get medical advice/attention. If eye irritation persists: Take off contaminated clothing and wash before reuse. Dispose of contents/ container to an approved waste disposal plant

Other References

Merck
14,3547
Beilstein
47549
Harmonized Tariff Code
2932.20
TSCA
No
RTECS
DJ2620000

Recommended

  • A10772

    Triethylene glycol, 99%
  • A11766

    Allyl bromide, 99%, stab. with 300-1000ppm Propylene oxide
  • A12398

    (S)-(-)-Nicotine, 99%
  • A12475

    5-Hydroxymethyl-2-furaldehyde, 97%
  • J62282

    Ethidium bromide soln., 10mg/ml

Recently Viewed

Chemicals

Life Science

Metals & Materials

Catalysts

Analytical & Labware